GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 111 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,062,000 | +61.9% | 44,400 | -1.1% | 0.01% | +50.0% |
| Q4 2020 | $656,000 | +2.8% | 44,900 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $638,000 | -81.5% | 44,900 | -80.9% | 0.01% | -81.2% |
| Q2 2020 | $3,456,000 | +207.5% | 234,900 | -13.8% | 0.05% | +166.7% |
| Q1 2020 | $1,124,000 | -12.8% | 272,600 | 0.0% | 0.02% | +38.5% |
| Q4 2019 | $1,289,000 | -22.0% | 272,600 | 0.0% | 0.01% | -27.8% |
| Q3 2019 | $1,652,000 | – | 272,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |